First quarter 2026 results: EUR 225 million net income in Q1 2026
Go back to First quarter 2026 results: EUR 225 million net income in Q1 2026| Simcere Pharmaceutical Group (NASDAQ: SCR) | Delayed: 35.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.58 | 52 Week High | $9.77 | |||
| Open | $21.80 | 52 Week Low | $7.25 | |||
| Day High | $35.58 | P/E | N/A | |||
| Day Low | $35.58 | EPS | $0.00 | |||
| Volume | 21,881 | |||||
